Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1440 |
---|---|
Product Name | Anti-Human IL23A Recombinant Antibody(Brazikumab) |
Molecular Name | Brazikumab |
Alias | Anti-IL23A Recombinant Antibody, Research Grade Brazikumab |
CAS Number | 1610353-18-8 |
Target | IL23A[Homo sapiens] |
Isotype | IgG2 Lambda |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, IHC, FCM, IP, IF, Inhib, PK |
Buffer | PBS, pH7.5 |
Background | Brazikumab (INN, development code MEDI2070) is a human monoclonal antibody designed for the treatment of Crohn's disease. This drug was developed by MedImmune. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |